IL2 and diphtheria: Mice which had received all three shots of Infanrix® IPV and were sacrificed 7 days after the third shot had significantly more diphtheria-specific CD4+ T cells producing IL-2, IL-6, or TNF-α when treated with GM-CSF than placebo-treated controls (Fig. 3C).